Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- S.3335
S.3335: Fair Accountability and Innovative Research Drug Pricing Act of 2016
About This Bill
- This bill was introduced in the 114th Congress
- This bill is primarily about health
- Introduced Sept. 15, 2016
- Latest Major Action Sept. 15, 2016
- See the four similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsors
3 (1 Democrat, 2 Republicans)
Bill Version
- Introduced in Senate - Sept. 15, 2016
Bill Summary
Fair Accountability and Innovative Research Drug Pricing Act of 2016 This bill amends the Public Health Service Act to require manufacturers of certain drugs and biological products to report to the Department of Health and Human Services (HHS) price increases that result in a 10% or more increase in the price of a drug over a 12-month period. Reports are required for prescription drugs and drugs commonly administered in hospitals, except...
(Source: Library of Congress)
Bill Actions
| Date | Description |
|---|---|
| Sept. 15, 2016 |
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
|
| Sept. 15, 2016 |
Introduced in the Senate by Tammy Baldwin (D-Wis.) |